Glycated hemoglobin for the diagnosis of diabetes and prediabetes: Diagnostic impact on obese and lean subjects, and phenotypic characterization

Journal of Diabetes Investigation

Volumn 6, Issue 1, 2015, Pages 44-50

  Incani, Michela ^a   Sentinelli, Federica ^b   Perra, Laura ^a   Pani, Maria Grazia ^a   Porcu, Marta ^a   Lenzi, Andrea ^b   Cavallo, Maria Gisella ^b   Cossu, Efisio ^a   Leonetti, Frida ^b,c   Baroni, Marco Giorgio ^a,b,c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Eleonora Lorillard Spencer Cenci Foundation   (Italy)

Author keywords

Glycated hemoglobin; Obesity; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY;

EID: 84920280557     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12241     Document Type: Article

References (21)

1. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2013; 36(Suppl. 1): S11-S66.
2. van't Riet E, Alssema M, Rijkelijkhuizen JM, et al. Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study. Diabetes Care 2010; 33: 61-66.
3. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 2006; 29: 1263-1268.
4. Zemlin AE, Matsha TE, Hassan MS, et al. HbA1c of 6.5% to diagnose diabetes mellitus - does it work for us? the Bellville South Africa study. PLoS One 2011; 6: e22558.
5. Cavagnolli G, Comerlato J, Comerlato C, et al. HbA(1c) measurement for the diagnosis of diabetes: is it enough? Diabet Med 2011; 28: 31-35.
6. Buell C, Kermah D, Davidson MB. Utility of HbA1c for diabetes screening in the 1999 2004 NHANES population. Diabetes Care 2007; 30: 2233-2235.
7. Tanaka Y, Atsumi Y, Matsuoka K, et al. Usefulness of stable HbA1c for supportive marker to diagnose diabetes mellitus in Japanese subjects. Diabetes Res Clin Pract 2001; 53: 41-45.
8. Mann DM, Carson AP, Shimbo D, et al. Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care 2010; 33: 2190-2195.
9. Heianza Y, Hara S, Arase Y, et al. HbA1c 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet 2011; 9: 147-155.
10. Ziemer DC, Kolm P, Weintraub WS, et al. Glucose-independent, Black-White differences in hemoglobin A1c levels. Ann Intern Med 2010; 152: 770-777.
11. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol 2011; 8: 228-236.
12. Buckley CM, Madden J, Balanda K, et al. Pre-diabetes in adults 45 years and over in Ireland: the Survey of Lifestyle, Attitudes and Nutrition in Ireland 2007. Diabet Med 2013; 30: 1198-1203.
13. Marini MA, Succurro E, Castaldo E, et al. Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, post challenge glucose, and hemoglobin A1c criteria. Diabetes Care 2012; 35: 1144-1149.
14. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
15. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 2003; 26: 881-885.
16. Nathan DM, Davidson MB, DeFronzo RA, et al. American Diabetes Association. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30: 753-759.
17. Kramer CK, Araneta MR, Barrett-Connor E. A1C and diabetes diagnosis: the Rancho Bernardo Study. Diabetes Care 2010; 33: 101-103.
18. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010; 33: 562-568.
19. Carson AP, Reynolds K, Fonseca VA, et al. Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 2010; 33: 95-97.
20. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med 2003; 163: 2146-2148.
21. Choi SH, Kim TH, Lim S, et al. Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year community-based prospective study. Diabetes Care 2011; 34: 944-949.